The American Journal of Medicine
Volume 120, Issue 10, Supplement 1 , Pages S4-S5, October 2007

Cubicin Outcomes Registry and Experience (CORE) Methodology

  • Kenneth V.I. Rolston, MD

      Affiliations

    • M. D. Anderson Cancer Center, University of Texas, Houston, Texas, USA
    • ,
  • John Segreti, MD

      Affiliations

    • Rush University Medical Center, Chicago, Illinois, USA
    • ,
  • Kenneth C. Lamp, PharmD

      Affiliations

    • Cubist Pharmaceuticals, Inc., Lexington, Massachusetts, USA.
    • Corresponding Author InformationRequests for reprints should be addressed to Kenneth C. Lamp, PharmD, Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, Massachusetts 02421.
    • ,
  • Lawrence V. Friedrich, PharmD

      Affiliations

    • Cubist Pharmaceuticals, Inc., Lexington, Massachusetts, USA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Please see the Author Disclosure section at the end of this article.

PII: S0002-9343(07)00658-4

doi:10.1016/j.amjmed.2007.07.008

The American Journal of Medicine
Volume 120, Issue 10, Supplement 1 , Pages S4-S5, October 2007

Article Tools